ECSP972166A - SULFONAMIDES AND THEIR USE - Google Patents
SULFONAMIDES AND THEIR USEInfo
- Publication number
- ECSP972166A ECSP972166A ECSP972166A ECSP972166A EC SP972166 A ECSP972166 A EC SP972166A EC SP972166 A ECSP972166 A EC SP972166A EC SP972166 A ECSP972166 A EC SP972166A
- Authority
- EC
- Ecuador
- Prior art keywords
- halogen
- alkylamino
- signifies
- dialkylamino
- amino
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El presente invento se refiere a compuestos de fórmula general I: (gráfico), en donde Z significa un grupo de fenilo sustituído, piridilo sustituido, pirimidilo sustituído o indolilo sustituido de las fórmulas a-e (gráfico), R1 significa hidrógeno, amino, alquilamino inferior, dialquilamino inferior, alquilo inferior, halógeno o trifluorometilo; R2 significa hidrógeno o alquilo inferior; R3 significa hidrógeno, amino, alquilamino inferior, dialquilamino inferior, alquilo inferior, CF3.alcoxilo inferior o halógeno. R4 significa amino, alquilamino inferior, dialquilamino inferior, alquilo inferior, alcoxilo inferior o halógeno; R5 significa hidrógeno, alquilamino inferior, di-alquilamino inferior, alcoxilo inferior o halógeno; R6 significa alquilo inferior, alquilamino inferior, dialquilamino inferior, alcoxilo inferior, halógeno o CF3; R7 significa amino, alquilamino inferior, dialquilamino inferior, alcoxilo inferior, aquilsulfanilo inferior, mercapto, pirrolidin-1-ilo o azetidin-1-ilo; R8 significa amino, alquilamino inferior, di-alquilamino inferior, bencilamino, alcoxilo inferior, alquilsulfanilo inferior, halógeno, pirrolidin-1-iloo azetidin-1-ilo; R9 y R10 significan cada uno, independientemente, alcoxilo inferior o alquilamino inferior; R11 significa hidrógeno o halógeno; R12 significa hidrógeno o alquilo inferior, y a significa un doble enlace opcional, con la salvedad de que R7 y R8 no significan simultáneamente metoxilo, asi como sus sales farmacéuticamente aceptables, como sustancias terapeuticamente activas contra transtornos del sistema nervioso central y para la producción de medicamentos correspondientes.The present invention relates to compounds of general formula I: (graph), where Z means a substituted phenyl, substituted pyridyl, substituted pyrimidyl or substituted indolyl group of the formulas a and e (graph), R1 represents hydrogen, amino, lower alkylamino , dialkylamino lower, lower alkyl, halogen, or trifluoromethyl; R2 signifies hydrogen or lower alkyl; R3 means hydrogen, amino, lower alkylamino, dialkylamino lower, lower alkyl, CF3, lower alkoxy or halogen. R4 signifies amino, lower alkylamino, dialkylamino lower, lower alkyl, lower alkoxy or halogen; R5 signifies hydrogen, lower alkylamino, di-lower alkylamino, lower alkoxy or halogen; R6 signifies lower alkyl, lower alkylamino, dialkylamino lower, lower alkoxy, halogen or CF3; R7 signifies amino, lower alkylamino, dialkylamino lower, lower alkoxy, lower alkylsulfanyl, mercapto, pyrrolidin-1-yl or azetidin-1-yl; R8 signifies amino, lower alkylamino, di-lower alkylamino, benzylamino, lower alkoxy, lower alkylsulfanyl, halogen, pyrrolidin-1-yl or azetidin-1-yl; R9 and R10 each independently represent lower alkoxy or lower alkylamino; R11 signifies hydrogen or halogen; R12 means hydrogen or lower alkyl, it already means an optional double bond, with the exception that R7 and R8 do not simultaneously mean methoxy, as well as their pharmaceutically acceptable salts, as therapeutically active substances against disorders of the central nervous system and for the production of medicines corresponding.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972166 ECSP972166A (en) | 1997-06-26 | 1997-06-26 | SULFONAMIDES AND THEIR USE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972166 ECSP972166A (en) | 1997-06-26 | 1997-06-26 | SULFONAMIDES AND THEIR USE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972166A true ECSP972166A (en) | 1998-09-22 |
Family
ID=42042997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972166 ECSP972166A (en) | 1997-06-26 | 1997-06-26 | SULFONAMIDES AND THEIR USE |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972166A (en) |
-
1997
- 1997-06-26 EC ECSP972166 patent/ECSP972166A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4900073A1 (en) | SULFONAMIDES AND THEIR USE AGAINST CENTRAL NERVOUS SYSTEM DISORDERS, PROCESS OF PREPARATION OF NEW SULFONAMIDES AND MEDICINES THAT CONTAIN THEM | |
| GEP20074244B (en) | Compounds that modulate ppar activity and methods for their preparation | |
| ECSP055535A (en) | DERIVATIVES OF 1-HETEROCICLIALQUIL-3-SULFONILAZAINDOL OR AZAINDOL AS 5-HYDROXITRIPTAMINE-6 LIGANDS | |
| ECSP055536A (en) | DERIVATIVES OF 1-HETEROCICLILALQUIL-3-SULFONILINDOL OR INDAZOL AS LIGANDS OF 5-HYDROXITRIPTAMINE-6 | |
| AR034897A1 (en) | N-MONOACILATED DERIVATIVES OF O-PHENYLENDIAMINS, THEIR HETEROCICLICAL ANALOGS OF SIX MEMBERS AND THEIR USE AS PHARMACEUTICAL AGENTS | |
| HK1054039A1 (en) | Substituded beta-carbolines | |
| CO4810373A1 (en) | ARYL-CONDENSED AZAPOLYCLIC COMPOUNDS | |
| AR036075A1 (en) | COMPOUNDS DERIVED FROM PIRIMIDINA, TRIAZINA, AND, PIRAZINA, ITS USE, A PROCEDURE FOR THE PREPARATION AND MEDICINES THAT UNDERSTAND THEM | |
| HRP20020306B1 (en) | 6-position substituted indole, production and use thereof as a medicament | |
| ECSP045473A (en) | DERIVATIVES OF 1- (AMINOALQUIL) -3-SULFONYLINDOL AND 1-AMINOALQUIL-3-SULFONYLINDAZOL AS 5-HYDROXYTHYRIPTAMINE-6 LIGANDS | |
| AR067528A1 (en) | ETERES HETEROCICLICOS REPLACED AND ITS USE IN CNS DISORDERS | |
| ES2421948T3 (en) | Compounds and compositions for delivering active agents | |
| BR9811093A (en) | Pyridines replaced with 2-amino-6- (2-substituted 4-phenoxy) | |
| AR051686A1 (en) | PIRIDOTIENOPIRIMIDINE DERIVATIVES; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR EMPLOYMENT IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES MEDIATED BY PDE4 INHIBITION. | |
| DK1578740T3 (en) | 1,2,4-triaminobenzene derivatives suitable for the treatment of central nervous system disorders | |
| NO985599L (en) | Aryl-substituted cyclic amines as selective dopamine D3 ligands | |
| ES2187261B2 (en) | ETERES AND AMIDAS COMPOUNDS AND THEIR PREPARATION, AS ANTI-DIABETIC AGENTS. | |
| AR022413A1 (en) | USE OF PIRIDAZINO DERIVATIVES (4,5-B) INDOL-1-ACETAMIDE, FOR THE PREPARATION OF DRUGS INTENDED FOR DISEASES OF THE NERVOOSOCENTRAL SYSTEM | |
| CO4840509A1 (en) | 2,4 SUBSTITUTED DIAMINOPYRIMIDINES, MEDICINAL PRODUCT CONTAINING SUCH COMPOUNDS FOR THE CONTROL OR PREVENTION OF INFECTIOUS DISEASES AND PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS " | |
| AR013462A1 (en) | NEW PEPTIDOMIMETICOS FOR THE TREATMENT OF BONE DISORDERS, METHODS FOR ITS PRODUCTION AND DRUGS THAT CONTAIN THESE COMPOUNDS | |
| DK1194415T3 (en) | New piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing them and a process for their preparation | |
| SE9702563D0 (en) | Compounds | |
| AR068381A1 (en) | APPROPRIATE QUINOLINE COMPOUNDS TO TREAT DISORDERS THAT RESPOND TO THE MODULATION OF SEROTONINE 5-HT6 RECEPTOR | |
| CY1112057T1 (en) | THERAPEUTIC PRODUCTS FOR AUTOMATIC ADMINISTRATION | |
| ECSP972166A (en) | SULFONAMIDES AND THEIR USE |